Alembic Pharma received eight USFDA approvals in Q3FY24
Express Pharma
JANUARY 2, 2024
Alembic Pharmaceuticals has received US Food & Drug Administration (USFDA) approvals on eight of its Abbreviated New Drug Application (ANDA) in Q3FY24. The company has also received three tentative approvals that includes Rivaroxaban Tablets USP, 2.5 Dapsone gel, 7.5% Dapsone gel, 7.5%
87 
Let's personalize your content